ALLO

ALLOGENE THERAPEUTICS INC

ALLO·019770106·US·Common Stock·Healthcare - Biotechnology-Activist

ALLO (ALLOGENE THERAPEUTICS INC) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($46.6M), STATE STREET CORP ($21.1M), PRIMECAP MANAGEMENT CO/CA/ ($20.4M). Net institutional sentiment: Bullish.

118
Holders
(12 Elite)
$291.9M
Total Value
71% (112)
Consensus
80 buying - 32 selling
13F: Insider & Congress:
ALLOSmart Money Verdict
View all
Held by 118 funds
12 elite
Who's Trading
ActivistLYLynx1 Capital Management LP0.0%May 15, 2026
ActivistKenneth GriffinKenneth Griffin2.8%May 15, 2026
ActivistABArie Belldegrun, M.D.5.4%May 13, 2026
ActivistDDDavid D. Chang, M.D., Ph.D.4.9%May 13, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.4.7%Apr 23, 2026
InsiderYAYoshiyama AnnieSell $22KApr 21, 2026
InsiderBMBeneski Benjamin MachinasSell $7KMar 31, 2026
InsiderCDChang David DSell $118KMar 16, 2026
InsiderBMBeneski Benjamin MachinasSell $12KMar 16, 2026
InsiderBMBeneski Benjamin MachinasSell $19KMar 2, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
19.1M(+8.0%)$46.6M0.0%-5.89%
32
Increased
8.7M(+213.6%)$21.1M0.0%-33.53%
46
Increased
8.4M(+3.0%)$20.4M0.0%-82.86%
29
New
6.9M$16.9M0.0%-20.95%
39
Decreased
6.8M(-43.9%)$16.6M0.0%-18.34%
0
Increased
5.4M(+67.7%)$13.1M0.0%-46.76%
41
Increased
5.4M(+57.0%)$13.1M0.0%-26.31%
40
Increased
4.1M(+4.9%)$10.1M0.0%-81.88%
29
Increased
3.5M(+0.0%)$8.5M0.0%-65.56%
27
Increased
3.4M(+1107.4%)$8.4M0.0%-17.66%
44
Increased
3.3M(+80.4%)$8.1M0.0%+9.59%
42
Increased
3M(+30.0%)$7.3M0.0%+25.67%
34
Increased
2.8M(+20.8%)$6.7M0.0%+16.90%
33
Increased
2.8M(+115.4%)$6.7M0.0%+2.20%
44
Increased
2.5M(+73.8%)$6.1M0.0%+10.52%
41
Increased
2.3M(+751.1%)$5.6M0.0%-16.87%
44
Decreased
2.1M(-2.2%)$5.2M0.0%+23.94%
0
Increased
2.1M(+111.9%)$5.2M0.0%-12.98%
44
New
2M$4.9M0.0%-20.95%
37
New
1.7M$4.1M0.0%-20.95%
37

Showing 1-20 of 122

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used